The DAPT coprimary composite end point ( death , myocardial infarction [ MI ] , or stroke ) was lower with 30 compared with 12 months prasugrel treatment ( 3.7 % versus 8.8 % ; hazard ratio [ HR ] , 0.407 ; P < 0.001 ) .